Gene · 1763
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication. | Nat Commun | 2024 | 39284827 | PubTator, text mining | PubMed |
| Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination. | Nature | 2024 | 39261729 | PubTator, text mining | PubMed |
| Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection. | Nature | 2024 | 39261728 | PubTator, text mining | PubMed |
| Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China. | Emerg Microbes Infect | 2024 | 39234778 | PubTator, text mining | PubMed |
| Replication fork stalling in late S-phase elicits nascent strand degradation by DNA mismatch repair. | Nucleic Acids Res | 2024 | 39180395 | PubTator, text mining | PubMed |
| Senataxin RNA/DNA helicase promotes replication restart at co-transcriptional R-loops to prevent MUS81-dependent fork degradation. | Nucleic Acids Res | 2024 | 39119900 | PubTator, text mining | PubMed |
| ATM and 53BP1 regulate alternative end joining-mediated V(D)J recombination. | Sci Adv | 2024 | 39083600 | PubTator, text mining | PubMed |
| TRF2-RAP1 represses RAD51-dependent homology-directed telomere repair by promoting BLM-mediated D-loop unwinding and inhibiting BLM-DNA2-dependent 5'-end resection. | Nucleic Acids Res | 2024 | 39082275 | PubTator, text mining | PubMed |
| Proteasome-mediated degradation of long-range nucleases negatively regulates resection of DNA double-strand breaks. | iScience | 2024 | 39071887 | PubTator, text mining | PubMed |
| A novel split PEC sensor based on magneto-optic nanostructure and photocurrent polarity switching strategy. | Anal Chim Acta | 2024 | 38811134 | PubTator, text mining | PubMed |
| A novel mutation of DNA2 regulates neuronal cell membrane potential and epileptogenesis. | Cell Death Discov | 2024 | 38802339 | PubTator, text mining | PubMed |
| EXO1 and DNA2-mediated ssDNA gap expansion is essential for ATR activation and to maintain viability in BRCA1-deficient cells. | Nucleic Acids Res | 2024 | 38721777 | PubTator, text mining | PubMed |
| BLM helicase unwinds lagging strand substrates to assemble the ALT telomere damage response. | Mol Cell | 2024 | 38593805 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair. | Front Cell Dev Biol | 2024 | 38586304 | PubTator, text mining | PubMed |
| Variants in mitochondrial disease genes are common causes of inherited peripheral neuropathies. | J Neurol | 2024 | 38549004 | PubTator, text mining | PubMed |
| Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. | Nat Commun | 2024 | 38331987 | PubTator, text mining | PubMed |
| Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis. | Heliyon | 2024 | 38317984 | PubTator, text mining | PubMed |
| Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation. | Heliyon | 2024 | 38317891 | PubTator, text mining | PubMed |
| Loss of Dna2 fidelity results in decreased Exo1-mediated resection at DNA double-strand breaks. | J Biol Chem | 2024 | 38311177 | PubTator, text mining | PubMed |
| A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. | Sci Rep | 2024 | 38291084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1763/papers?page=5